Meetings/Workshops on Biotechnology in the United States (USA)

Submit a meeting

Select a location:
Belgium (2) - Canada (2) - France (2) - Germany (2) - India (2) - Italy (4) - Morocco (1) - Namibia (1) - Netherlands (1) - Portugal (1) - Singapore (2) - Spain (1) - Sri Lanka (1) - Thailand (2) - Tunisia (2) - United Arab Emirates (1) - United Kingdom (2) - United States (21) - ALL COUNTRIES (50)

1
Keystone Symposia: Precision Genome Editing with Programmable Nucleases
28 Jan 2018 - 01 Feb 2018 • Keystone, Colorado, United States
Abstract:
Genome editing refers to the use of programmable DNA-targeting platforms to manipulate genetic and epigenetic information in living cells and organisms. Genome editing has been recently democratized by the development of RNA-guided endonucleases repurposed from CRISPR-Cas microbial defense systems against viruses or plasmids. Whereas novel tools such as Cpf1 and RNA-guided deaminases are being developed to expand the scope of genome editing, old tools such as ZFNs and TALENs are likely to undergo innovations as well. These tools enable genome-wide genetic screens in cell lines and genetic studies in both model and non-model organisms. Furthermore, genome editing holds great promise for broad applications in medicine and biotechnology, raising public interest and concerns. Yet genome editing is still limited by many factors such as inefficient delivery in vivo, off-target effects, and unwanted, alternative DNA repair. This conference offers opportunities to learn about new developments, advancements and applications in the field.
Contact:
Attendee Services;     Phone: [970.262.1230 or 800.253.0685];     Email: info@keystonesymposia.org
Topics:
genetics, genomics, epigenetics, dna repair, biotechnology
Event listing ID:
926101
Related subject(s):
2
MMTC — Molecular Med Tri-Con 2018
11 Feb 2018 - 16 Feb 2018 • San Francisco, United States
Abstract:
Since its debut in 1993, the annual Molecular Medicine Tri-Conference has become one of the world's leading international events in the field of drug discovery, development and diagnostics. The Tri-Conference unites an ecosystem of 3,700 innovative thinkers and thought leaders throughout biotech, pharma and academia from around the world. Spanning five days, the 2018 meeting includes 16 parallel conference tracks, 7 Symposia, and 25 in-depth short courses. We are also interested in offering new skills-based training programs. Compelling talks, including best practice case studies and joint partner presentations, will feature over 500 of your fellow industry and academic colleagues discussing themes of cancer research, big data, molecular diagnostics, precision medicine, rare diseases, data science, human microbiome, point-of-care diagnostics, infectious diseases, and so much more.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: chi@healthtech.com
Topics:
drug discovery, drug development, diagnostics, biotech, biotechnology
Event listing ID:
942672
Related subject(s):
3
FOGM18 — The Future of Genomic Medicine
01 Mar 2018 - 02 Mar 2018 • La Jolla, United States
Abstract:
The 11th annual Future of Genomic Medicine conference will be the next iteration of taking genomic knowledge to transform the daily practice of medicine. To do this, we have patients present their story of how genomics affected their medical status, and have a faculty of experts in genomics, science and medical journalism, and the life science industry provide critical perspective. This year we will be paying attention to the exciting area of genomic editing to treat diseases, cancer (a disease of the genome), and the use of genetics for preventative medicine. Furthermore, we will delve into the hot topics of circulating free DNA-based diagnostics, epigenetics, and genomic analytics. The overarching goal of the conference is to spearhead efforts to use genomic knowledge to change medicine and make it far more precise and individualized.
Contact:
Corrine Yarbrough;     Phone: [8587842133];     Email: cyarbro@scripps.edu
Topics:
The Future of Idividualized Medicine, Genome Editing, Data Science in Genetics and Genomics, Genetics of Human Origins and Adaptation, Circulating DNA and RNA, Predictive and Preventative Genetics, Epigenetics
Event listing ID:
984087
4
Course — Particles in Biotherapeutics: Characterization & Impact (Part of Biotherapeutics Analytical Summit 2018)
12 Mar 2018 • Baltimore, United States
Abstract:
This short course will give an introduction to current issues surrounding particle formation & characterization in biotherapeutics. Regulatory expectations provide the context of why particle loads are characterized and controlled. The basics of why and how proteins can aggregate will be presented along with a discussion of other particle types. An overview of the recent technology to accurately characterize various classes of aggregates and particles will be discussed. Studies from the current literature will be used to highlight various key points throughout the course.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989658
5
Course — The Multi-Attribute Method (MAM) for Improving Product and Process Development (Part of Biotherapeutics Analytical Summit 2018)
12 Mar 2018 • Baltimore, United States
Abstract:
During biotherapeutic development, it is necessary to monitor properties of the therapeutic molecule and formulation that have been identified as critical quality attributes (CQAs) for product safety and efficacy. In particular, the industry is seeking to monitor post-translational modifications (PTMs), glycosylation profiles, and excipients with both UV and mass data by implementing multi-analyte or so-called Multi Attribute Methods (MAMs). The course offers hands-on training on how to apply the Multi-Attribute Method (MAM) to mass spectrometry data. We will be performing attribute analytics (quantifying product quality attributes) and new peak detection (purity test) on mass spec data. During the course, we will discuss the uses of the MAM in process development and in a QC lab.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989624
6
Method Development, Qualification & Validation (Part of Biotherapeutics Analytical Summit 2018)
12 Mar 2018 - 13 Mar 2018 • Baltimore, United States
Abstract:
From method development to qualification to validation and transfer, it is a continuous yet inter-dependent process from early research to development to QC and release. Depending on which stage of product development you are in, your method may or may not need to be robust, qualified or validated. The objective is to prove that methods selected are fit for their intended purpose.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989587
7
Characterizing Aggregates & Impurities (Part of Biotherapeutics Analytical Summit 2018)
12 Mar 2018 - 13 Mar 2018 • Baltimore, United States
Abstract:
Product and process-related impurities impact biopharmaceutical development at every stage from discovery to development to manufacturing. Detecting, identifying and characterizing these variants and impurities are of high regulatory concern, due to the potential correlation between aggregation and increased immunogenicity of the biotherapeutics.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989564
8
BCC — Biotherapeutics Analytical Summit 2018
12 Mar 2018 - 16 Mar 2018 • Baltimore, United States
Abstract:
The Biotherapeutics Analytical Summit, with its hallmark brand of topics on Method Development, Qualification & Validation, Advances in Characterization Methods & Approaches and Comparability & Biosimilarity, and its signature mix of regulators, industry and academia speakers, has come to be known as THE Analytical Summit where attendees can hear and learn about real-life case studies, innovative concepts and practical approaches that can help scientists advance their molecules from discovery to development and commercialization.
Contact:
Jason Gerardi;     Phone: [781-972-5452];     Email: chi@healthtech.com
Topics:
Biotherapeutics, Method Development, Qualification, Validation, Characterization Methods, Characterization Approaches, Comparability & Biosimilarity
Event listing ID:
958862
Related subject(s):
9
Advances in Characterization Methods & Approaches (Part of Biotherapeutics Analytical Summit 2018)
13 Mar 2018 - 14 Mar 2018 • Baltimore, United States
Abstract:
From early developability screening to assessing glycosylation and higher order structure, analytical techniques play an important role in identifying and characterizing the physico-chemical properties of the molecules, allowing scientists to better understand, control and optimize their molecules’ properties.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989629
10
Comparability & Biosimilarity (Part of Biotherapeutics Analytical Summit 2018)
13 Mar 2018 - 14 Mar 2018 • Baltimore, United States
Abstract:
The 4th Annual Comparability and Biosimilarity conference continues to build upon the past years’ discussion on regulatory requirements and guidelines on comparability and biosimilarity assessments; analytical strategies and techniques to evaluate batch-to-batch comparability during process, site or manufacturing changes; equivalence testing of biosimilars with innovator products plus the use of mathematical modeling and statistical data to establish analytical biosimilarity; as well as strategies toward ICH harmonization in comparability and biosimilarity.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989595
11
Course — Core Principles and Best Practices for Biotech Analytical Test Methods across the Product Lifecycle (Part of Biotherapeutics Analytical Summit 2018)
13 Mar 2018 - 14 Mar 2018 • Baltimore, United States
Abstract:
Current GMP requirements for test method validation are quite clear: Methods used for GMP product testing must be validated to demonstrate they can produce accurate and reliable results. But FDA and EU guidances are less clear about method ‘validation’ during product development. On the one hand, they indicate method validation is an evolving process, but on the other they state that method validation data should be available upon request at Phase II and Phase III. These guidances also indicate that test methods only need to be qualified for Phase I (except safety methods, which do require validation prior to Phase I). Methods used only for product or process characterization, comparability or similarity also need to be qualified to demonstrate they are scientifically sound. Some of these methods will start out in non-GMP labs then transfer to GMP labs; others will only ever be used in non-GMP labs. But during development, even data generated in non-GMP studies are critical for making process and product decisions, and are reported in product dossiers as supportive information. Although there is guidance on lab data integrity in GMP labs, there are no current guidance documents on data integrity in non-GMP labs.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989550
12
Course — Critical Quality Attributes and Testing Strategy for Biotherapeutics Development (Part of Biotherapeutics Analytical Summit 2018)
14 Mar 2018 • Baltimore, United States
Abstract:
Biotherapuetics are challenging to develop due to complexity of the molecular structure as well as the manufacturing process. Identification of product critical quality attributes (CQAs) is an important component in the development of a robust control strategy using the Quality-by-Design approach. In this short course, we will discuss the key concepts of CQA risk ranking based on potential impact on safety and efficacy, defining control strategies, the common analytical characterization technologies used, and the considerations for development of an integrated testing strategy.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989634
13
Course — New Analytical Approaches & Strategies for Biosimilarity (Part of Biotherapeutics Analytical Summit 2018)
14 Mar 2018 • Baltimore, United States
Abstract:
Providing convincing analytical similarity studies is a key success factors for the filing of biosimilars. For proper planning of novel or biosimilar development programs, it is important to understand the development costs, timelines and the authoring of CMC regulatory sections. The analytical characterization of comparability and similarity studies will form the cornerstone for each successful marketing authorization application of these products. This short course will focus on analytical development and its challenges, technical hurdles, BLA authoring, timelines and costs. Participants will be introduced to state-of-the art analytical similarity strategies, which anticipate occurrences of non-identity between biosimilar and originator, leading to a smooth and efficient IND/BLA application and approval.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989644
14
Seminar — Regulatory Requirements across the Product Development Lifecycle (Part of Biotherapeutics Analytical Summit 2018)
15 Mar 2018 - 16 Mar 2018 • Baltimore, United States
Abstract:
The successful development of a pharmaceutical product requires not only good science, but also compliance with FDA regulatory expectations. This course will include a comprehensive review of the Chemistry, Manufacturing and Controls (CMC) section of regulatory filings, with a focus on phase appropriate requirements. The level of detail that must be included in the filing will be discussed as well as systems and controls that must be in place in the manufacturing setting. Topics such as process development, analytical development, Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) will be discussed in the context of the stage of drug development. Regulatory strategies for navigating the path to approval will also be discussed. This course is intended to provide participants from all facets of the pharmaceutical and biotech industry with a broad understanding of regulatory requirements across the product development lifecycle.
Contact:
Cambridge Healthtech Institute;     Phone: [781.972.5400];     Email: CHI@healthtech.com
Event listing ID:
989604
15
International Pharmaceutical Conference and Expo
21 Mar 2018 - 23 Mar 2018 • Philadelphia, United States
Abstract:
International Pharmaceutical Conference and Expo (iPharma 2018) cordially welcomes you to the City of Philadelphia, USA during March 21-23, 2018. Conference will witness academicians and business professionals discussing the soundest issues related to pharmaceuticals and will offer unparalleled business opportunities and access to new markets in Pharma, Medical and Health Care Industry.
Contact:
Serena Mastin;     Phone: [(619) 378-4793];     Email: serena@ipharmaconference.com
Topics:
Conference sessions include but not limited to: Pharmaceutics, Drug Discovery, Drug Delivery Systems, Drug Designing, Neuropharmacology, Drug therapy, Pharmacogenomics, Pharmacovigilance, Biopharmaceuticals, Nutraceuticals, Drug Development, Pharmaceutical Manufacturing, Quality Risk Management, Generic Drugs, Orphan Drugs, Clinical trials, Regulatory affairs, Drug formulations, Green Chemistry, Molecular Diagnostic, Separation Techniques and more.
Event listing ID:
938356
16
Keystone Symposia: Organs- and Tissues-on-Chips
08 Apr 2018 - 12 Apr 2018 • Big Sky, Montana, United States
Abstract:
More than 30% of promising medications have failed in human clinical trials because they are determined to be toxic despite promising pre-clinical studies in 2-D cell culture and animal models. Another 60% fail due to lack of efficacy. Consequently, though several thousand diseases affect humans, only about 500 have approved treatments. However, with the growing understanding of human biology, along with increased availability of innovative technologies, there is now an unprecedented opportunity to translate scientific discoveries more efficiently into new, more effective and safer health interventions. Organs- or Tissues-on-Chips are innovative, alternative approaches that would enable early indications and potentially more reliable readouts of toxicity and efficacy. These microfabricated devices recapitulate the multicellular architectures, tissue-tissue interfaces, physicochemical microenvironments, vascular perfusion and innervation, producing in essence microphysiological systems that mimic human tissue and organ functionality not possible with conventional 2D or 3D culture systems. Through innovative biosensing and readout approaches, these devices employ high-resolution, real-time imaging and non-invasive analysis of biochemical, genetic and metabolic activities of living cells in a functional tissue and organ context. This technology has great potential to advance the study of tissue development, organ physiology and disease etiology. In the context of drug discovery and development, it should be especially valuable for the study of molecular mechanisms of action, prioritization of lead candidates, toxicity testing and biomarker identification. These microfabricated devices have also proven to be useful for modeling human diseases. This conference will touch on ongoing efforts and various applications of tissue-on-chips technology to studies in precision medicine, environmental exposures, reproduction and development, cancer and for use at the International Space Station.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
nanotechnology, biotechnology, biosensing, tissue development, organ physiology, disease etiology, drug discovery and development
Event listing ID:
948484
17
Biotech-2018 — International Biotechnology Conference
25 Apr 2018 - 27 Apr 2018 • Rome, United States
Abstract:
International Biotechnology Conference will be held during April 25-27, 2018 at Rome, Italy. Biotech-2018 brings upon a new platform to share and discuss all the innovations in the field of Biotechnology and its allied areas. Biotech-2018 will focus on most recent progressions and technologies in this field. This conference is a gathering of all eminent persons, scientists and professors of biotechnology from all over world.
Contact:
Santosh MJ;     Phone: [3022316959];     Email: biotech@madridge.com
Topics:
Food Biotechnology, Cell and Molecular Biology, Applied Biochemistry
Event listing ID:
916022
18
International Biotechnology Conference
25 Apr 2018 - 27 Apr 2018 • USA, United States
Abstract:
International Biotechnology Conference will be held during April 25-27, 2018 at Rome, Italy. Biotech-2018 brings upon a new platform to share and discuss all the innovations in the field of Biotechnology and its allied areas.  Biotech-2018 will focus on most recent progressions and technologies in this field. This conference is a gathering of all eminent persons, scientists and professors of biotechnology from all over world.
Event listing ID:
937711
19
Gordon Research Conference — Drug Metabolism
08 Jul 2018 - 13 Jul 2018 • Holderness School, Holderness, NH, United States
Abstract:
The 48th Drug Metabolism Gordon Research Conference will focus on cutting edge research in drug ADME (absorption, distribution, metabolism, elimination), encompassing a wide range of research from the cellular level to the patient. Complexity in biological systems and enzymatic processes is continually uncovered in science. The conference aims to illuminate this biological complexity, often studied with simple biological and mathematical models, in order to enhance the application of new knowledge to understanding drug safety and efficacy in the clinic.
Event listing ID:
953733
20
Gordon Research Seminar — Drug Carriers in Medicine and Biology
11 Aug 2018 - 12 Aug 2018 • Mount Snow, West Dover, VT, United States
Abstract:
The 2018 Gordon Research Seminar on Drug Carriers in Medicine and Biology is the third biennial forum for young researchers to present data and exchange ideas in the areas of materials, immunology, and drug delivery. The Drug Carriers GRS provides a platform for graduate students, post-docs, and biotech/pharmaceutical professionals to build a scientific network in an informal setting designed to facilitate scientific discussions and idea generation.
Event listing ID:
953767
Related subject(s):
21
Gordon Research Conference — Drug Carriers in Medicine and Biology
12 Aug 2018 - 17 Aug 2018 • Mount Snow, West Dover, VT, United States

View all listed conferences in the United States (USA).



Conference-Service.com offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

AIP Conference Proceedings
 Integrated Gulf Biosystems
Last updated: 19 December 2017